Hirohisa Takano Selected Research

diisononyl phthalate

2/2014	Effects of oral administration of di-(2-ethylhexyl) and diisononyl phthalates on atopic dermatitis in NC/Nga mice.
4/2010	Effects of diisononyl phthalate on atopic dermatitis in vivo and immunologic responses in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirohisa Takano Research Topics

Disease

71	Inflammation (Inflammations) 08/2023 - 01/2002
40	Pneumonia (Pneumonitis) 09/2022 - 05/2002
39	Asthma (Bronchial Asthma) 09/2022 - 01/2002
17	Eosinophilia 01/2017 - 01/2008
13	Acute Lung Injury 04/2010 - 12/2002
12	Lung Injury 11/2013 - 04/2002
11	Atopic Dermatitis (Atopic Eczema) 12/2023 - 08/2006
11	Hypersensitivity (Allergy) 12/2023 - 11/2005
11	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2022 - 04/2002
7	Body Weight (Weight, Body) 01/2019 - 04/2004
6	Respiratory Hypersensitivity 09/2022 - 12/2002
6	Shock 04/2010 - 03/2005
6	Disseminated Intravascular Coagulation 04/2010 - 03/2005
6	Pancreatitis 04/2010 - 03/2005
5	Infections 01/2021 - 10/2004
5	Obesity 01/2019 - 10/2003
5	Lung Diseases (Lung Disease) 02/2014 - 04/2003
4	Allergic Rhinitis 11/2018 - 09/2007
4	Edema (Dropsy) 02/2018 - 05/2002
4	Hemorrhage 01/2013 - 05/2002
4	Arthritis (Polyarthritis) 01/2007 - 08/2003
3	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2007
3	Hyperplasia 08/2019 - 08/2007
3	Peritonitis 02/2013 - 09/2003
3	Pulmonary Emphysema 11/2010 - 03/2010
3	Pulmonary Edema 09/2006 - 12/2002
2	Neoplasms (Cancer) 12/2023 - 09/2013
2	COVID-19 01/2021 - 12/2020
2	Disease Progression 01/2020 - 03/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2017 - 07/2005
2	Fibrosis (Cirrhosis) 01/2015 - 03/2011
2	Skin Diseases (Skin Disease) 02/2014 - 03/2009
2	Colitis 05/2013 - 08/2004
2	Emphysema 11/2010 - 03/2010

Drug/Important Bio-Agent (IBA)

44	CytokinesIBA 08/2023 - 01/2002
32	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 08/2023 - 04/2002
31	Vehicle Emissions (Emissions, Vehicle)IBA 08/2023 - 04/2002
26	AllergensIBA 12/2023 - 01/2002
25	LipopolysaccharidesIBA 01/2017 - 12/2002
20	Particulate MatterIBA 01/2022 - 09/2006
19	SandIBA 07/2017 - 11/2005
17	ChemokinesIBA 09/2022 - 05/2002
14	OvalbuminIBA 01/2016 - 07/2002
14	EndotoxinsIBA 02/2011 - 05/2002
13	AntigensIBA 01/2014 - 12/2002
12	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2003
11	Immunoglobulin G (IgG)IBA 09/2022 - 01/2002
9	Immunoglobulins (Immunoglobulin)IBA 09/2022 - 07/2002
9	Diethylhexyl Phthalate (DEHP)IBA 10/2021 - 08/2006
9	Organic Chemicals (Chemicals, Organic)IBA 07/2017 - 11/2004
8	Proteins (Proteins, Gene)FDA Link 11/2010 - 04/2002
7	Immunoglobulin E (IgE)IBA 09/2022 - 01/2002
7	InterleukinsIBA 01/2021 - 06/2004
7	Interleukin-5 (Interleukin 5)IBA 11/2020 - 01/2002
7	phthalic acid (phthalate)IBA 07/2017 - 08/2006
7	Chemotactic FactorsIBA 02/2013 - 04/2004
7	urinastatin (MR 20)IBA 04/2010 - 03/2005
6	MetallothioneinIBA 05/2013 - 01/2005
6	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2010 - 03/2005
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2002
4	Environmental Pollutants (Pollutants, Environmental)IBA 12/2023 - 05/2002
4	LipidsIBA 08/2023 - 12/2012
4	CarbonIBA 09/2017 - 09/2006
4	GlucansIBA 04/2016 - 07/2005
4	Interleukin-13IBA 01/2015 - 08/2005
4	SootIBA 04/2011 - 09/2006
4	Rosmarinic AcidIBA 07/2006 - 04/2003
3	Blood Glucose (Blood Sugar)IBA 08/2023 - 04/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2014
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
3	Benzo(a)pyreneIBA 12/2021 - 11/2016
3	bisphenol AIBA 01/2019 - 01/2016
3	PlasticizersIBA 07/2017 - 05/2009
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014 - 04/2002
3	Pancreatic Elastase (Elastase)IBA 04/2011 - 03/2010
3	Carbon Nanotubes (Carbon Nanotube)IBA 04/2010 - 12/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010 - 01/2004
3	AntioxidantsIBA 10/2009 - 12/2002
3	Vitamin E FDA LinkGeneric 10/2004 - 12/2002
2	titanium dioxide (Titania)FDA Link 12/2021 - 03/2009
2	CholesterolIBA 01/2021 - 04/2004
2	Air Pollutants (Pollutants, Air)IBA 01/2021 - 07/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 01/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 08/2019 - 01/2016
2	Drinking WaterIBA 01/2019 - 08/2004
2	EstersIBA 07/2017 - 05/2009
2	quinone (benzoquinone)IBA 06/2017 - 01/2005
2	ElementsIBA 12/2016 - 04/2016
2	LigandsIBA 04/2016 - 03/2011
2	diisononyl phthalateIBA 02/2014 - 04/2010
2	PeroxiredoxinsIBA 12/2012 - 10/2009
2	OzoneIBA 12/2012 - 12/2008
2	Therapeutic UsesIBA 06/2012 - 05/2011
2	InflammasomesIBA 01/2012 - 10/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2010 - 03/2010
2	Methacholine Chloride (Methacholine)FDA Link 11/2010 - 03/2010
2	Alkaline PhosphataseIBA 11/2010 - 03/2010

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2015 - 12/2008